Skip to main content
. 2016 Oct 19;2016:3607924. doi: 10.1155/2016/3607924

Figure 3.

Figure 3

Inhibition zone of ligands, complexes, salt, and commercial antibiotics against (a) Gram-positive (S. aureus and MARSA) and (b) Gram-negative (K. pneumoniae and E. coli) bacteria.